Singular Genomics Systems Inc (OMIC)
0.4037
+0.01
(+2.72%)
USD |
NASDAQ |
May 21, 16:00
0.3993
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.072M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.618M |
March 31, 2023 | 0.006M |
December 31, 2022 | 0.75M |
September 30, 2022 | 0.027M |
June 30, 2022 | 0.101M |
March 31, 2022 | 0.023M |
Date | Value |
---|---|
December 31, 2021 | 0.81M |
September 30, 2021 | -1.32M |
June 30, 2021 | 239.15M |
March 31, 2021 | 133.48M |
December 31, 2020 | 0.028M |
September 30, 2020 | -0.023M |
June 30, 2020 | 0.00 |
March 31, 2020 | 7.51M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.32M
Minimum
Sep 2021
239.15M
Maximum
Jun 2021
22.43M
Average
0.028M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
Azenta Inc | -74.07M |
Harvard Bioscience Inc | -1.055M |
Standard BioTools Inc | -19.73M |
Bionano Genomics Inc | -21.62M |
Akoya Biosciences Inc | -0.444M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -23.70M |
Cash from Investing (Quarterly) | 31.58M |
Free Cash Flow | -80.25M |
Free Cash Flow Per Share (Quarterly) | -0.321 |
Free Cash Flow to Equity (Quarterly) | -22.45M |
Free Cash Flow Yield | -271.2% |